Updated:
Age 1
age1 funds breakthrough longevity companies addressing the core challenges of the field. It helps contrarian founders build generational biotech companies...
Overview
age1 funds breakthrough longevity companies addressing the core challenges of the field. It helps contrarian founders build generational biotech companies and is building a pragmatic, rigorous, and optimistic longevity community. Its expertise is the earliest stage possible, typically before any money has been raised, writing checks from $500,000 to $4M for founders developing therapeutics, tools, and technologies targeting aging and age-related disease.
General information
Firm type
Private Equity
Year founded
2023
Location
Region
North America
Country
United States
City
Las Vegas
Corporate office
San Francisco, United States
Principals
Alex Colville
Co-Founder, General Partner
Laura Deming
Co-Founder, Venture Partner
Satvik Dasariraju
Principal
Carol Magalhaes
NewCo Chief of Staff
Maggie Li
Special Projects Lead
Lauren Naworski
Venture Fellow
Doug Henze
Venture Fellow
Lynetta Wang
Venture Intern
Sector focus
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: